Skip to content

Pre-operative Very Low-calorie Protein-based Versus Hypocaloric Enteral Nutrition

Pre-operative Very Low-calorie Protein-based Versus Hypocaloric Enteral Nutrition to Improve Intra- and Post-operative Outcomes of Severely Obese Patients Undergoing Bariatric Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02418975
Enrollment
140
Registered
2015-04-17
Start date
2015-04-30
Completion date
2017-12-31
Last updated
2017-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative/Postoperative Complications

Brief summary

Pre-operative weight loss can reduce the risk intra- and post-operative complications but no optimal pre-operative weight loss strategy has been investigated. Very-low-calorie diets (VLCDs) were proven to results in higher metabolic improvements in the short-term than balanced, hypocaloric diets. Therefore, the aim of the study is to investigate whether a VLCD results in lower intra-and post-operative complications compared to a hypocaloric diet. However, to achieve a optimal compliance in patients having experienced multiple dietary intervention failures, administration of the intervention will be performed by the enteral route using a naso-gastric feeding tube.

Detailed description

Bariatric surgery is an important treatment strategy for obese patients having failed multiple diet-induced weight loss attempts. On the other hand, severly obese patients have also a high risk of both intra- and post-operative complications. Pre-operative weight loss can reduce these risks but no optimal pre-operative weight loss strategy has been investigated. Very-low-calorie diets (VLCDs) were proven to results in higher metabolic improvements in the short-term than balanced, hypocaloric diets. Therefore, the aim of the study is to investigate whether a VLCD results in lower intra-and post-operative complications compared to a hypocaloric diet. However, to achieve a optimal compliance in patients having experienced multiple dietary intervention failures, administration of the intervention will be performed by the enteral route using a naso-gastric feeding tube.

Interventions

OTHERVery low-calorie protein-based diet

Patients will receive a homemade very low-calorie (\ 5 kcal/kg of ideal body weight /day) protein-based formula (milk proteins; 1.2 g per kilogram of ideal body weight) for 4 weeks by a polyurethane nasogastric feeding tube.

Patients will receive a commercial balanced enteral formula (\ 20 kcal/kg of ideal body weight /day; protein content, 1.0 g per kilogram of ideal body weight) for 4 weeks by a polyurethane nasogastric feeding tube.

Sponsors

San Giuseppe Moscati Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patient candidate to laparoscopic bariatric surgery (gastric bypass or sleeve gastrectomy) after multi-disciplinary pre-operative evaluation * Availability to long-term post-operative follow-up * Normal kidney function serum creatinine ≤ 1,2 mg/dL and glomerular filtration rate ≥ 90 mL/min * Normal liver function (aspartate amino-transferase and/or alanine amino-transferase and/or gamma glutamyl transferase \< 2 x N) * written informed consent

Exclusion criteria

* age \<18 or \>60 anni * serum creatinine \>1,2 mg/dl * liver failure (Child-Pugh ≥ A) * insuline-dependent diabetes mellitus * atrioventricular block with QT \> 0,44 ms * Cardiac arrythmias * Moderate-severe cardiac failure * Hypokaliemia * Chronic diarrhoea or vomitus * 12-month previous cardio-vascular disease * pregnancy and/or lactation * current/previous neoplastic disease * psychiatric disorders * know gastro-intestinal diseases * other controindications to enteral nutrition * moderate-severe hypo-albuminemia (\<3.0 mg/dL) * 6-month previous diet-induced weight loss * intragastric balloon * unavailability to planned measurements

Design outcomes

Primary

MeasureTime frameDescription
Surgery durationEnd of surgery, an expected average of 3.5 hoursfrom skin incision to wound closure

Secondary

MeasureTime frameDescription
Composite intra-operative complicationsEnd of surgery, an expected average of 3.5 hoursHemorrhage, organ perforation or laceration, conversion to open surgery, stapler dysfunction
Composite post-operative complications30 daysAny-type hemorrhage, any-type infections, wound dehiscence, anastomotic leak, organ dysfunction
Intra-operative bleedingEnd of surgery, an expected average of 3.5 hours
Difficult intubationBefore surgery
Time to remove surgical drainHospital stay, an avarage of 9 days
Total drain fluid productionHospital stay, an avarage of 9 days
Change of multiple biochemical parametersEnd of dietary intervention, 28 daysblood lipids, variables of glucose metabolism and growth-hormone axis
Change in liver fibrosisEnd of dietary intervention, 28 days
Change in liver volumeEnd of dietary intervention, 28 days
Change in visceral fatEnd of dietary intervention, 28 days
Change of multiple body composition parametersEnd of dietary intervention, 28 days
Change in handgrip strengthEnd of dietary intervention, 28 days
Change of multiple cardiac morpho-functional parametersEnd of dietary intervention, 28 days
Length of hospital stayHospital stay, an avarage of 9 days
Composite complications of enteral feedingEnd of dietary intervention, 28 daystube dysfunction, nausea, vomiting, diarrhea
Change of multiple anthropometric parametersEnd of dietary intervention, 28 daysbody mass index, body weight, waist and hip circumferences

Countries

Italy

Contacts

Primary ContactGiuseppe Castaldo, MD
lavoronep@yahoo.it00390825203358

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026